David W. Osborne - Apr 21, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Chief Technical Officer
Signature
/s/ Scott Burrows, as Attorney-in-Fact for David W. Osborne, Ph.D.
Stock symbol
ARQT
Transactions as of
Apr 21, 2022
Transactions value $
-$44,872
Form type
4
Date filed
4/21/2022, 06:32 PM
Previous filing
Mar 7, 2022
Next filing
Jul 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale -$44.9K -2.2K -0.85% $20.42 257K Apr 21, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $20.125 to $20.925, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Includes 24,925 RSUs.